Over the last few months, many AI boosters have been increasingly interested in generative video models and their seeming ability to show at least limited emergent knowledge of the physical properties ...

I don’t know. It’s been such a dog. It’s been a dog, we had them on, twice the price. It’s done absolutely nothing. I need to see a proof of concept here.

Companies are already seeing measurable benefits and ROI from GenAI in the form of faster decisions, smarter workflows and new ways to connect with customers.

With competition in the GLP-1 category increasingly cutthroat, Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy was better than Eli Lilly's rival Zepbound at ...